Nasdaq:US$31.84 (-1.07) | HKEX:HK$54.80 (-0.35) | AIM:£5.08 (+0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713